Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained Dyspnea

• DOI: 10.1001/jamacardio.2022.1916
• Publication Date: 2022-07-13T15:36:25Z
• Authors: Yogesh N. V. Reddy; David M. Kaye; M. Louis Handoko; Arno A. van de Bo...; Ryan J. Tedford; Carson Keck; Mads J. Andersen; Kavita Sharma; Rishi K. Trivedi; Rickey E. Carter; Masaru Obokata; Frederik H. Verbr...; Margaret M. Redfield; Barry A. Borlaug
• Keywords: Heart Failure; Male; heart failure; Dyspnea/diagnosis; Stroke Volume; Middle Aged; preserved ejection fraction; Unexplained Dyspnea; Heart Failure/diagnosis; 3. Good health; 03 medical and health sciences; Dyspnea; 0302 clinical medicine; Case-Control Studies; Humans; Female; Aged; Retrospective Studies

Diagnosis of heart failure with preserved ejection fraction (HFpEF) among dyspneic patients without overt congestion is challenging. Multiple diagnostic approaches have been proposed but are not well validated against the independent gold standard for HFpEF diagnosis of an elevated pulmonary capillary wedge pressure (PCWP) during exercise.To evaluate H2FPEF and HFA-PEFF scores and a PCWP/cardiac output (CO) slope of more than 2 mm Hg/L/min to diagnose HFpEF.This retrospective case-control study included patients with unexplained dyspnea from 6 centers in the US, the Netherlands, Denmark, and Australia from March 2016 to October 2020. Diagnosis of HFpEF (cases) was definitively ascertained by the presence of elevated PCWP during exertion; control individuals were those with normal rest and exercise hemodynamics.Logistic regression was used to evaluate the accuracy of HFA-PEFF and H2FPEF scores to discriminate patients with HFpEF from controls.Among 736 patients, 563 (76%) were diagnosed with HFpEF (mean [SD] age, 69 [11] years; 334 [59%] female) and 173 (24%) represented controls (mean [SD] age, 60 [15] years; 109 [63%] female). H2FPEF and HFA-PEFF scores discriminated patients with HFpEF from controls, but the H2FPEF score had greater area under the curve (0.845; 95% CI, 0.810-0.875) compared with the HFA-PEFF score (0.710; 95% CI, 0.659-0.756) (difference, -0.134; 95% CI, -0.177 to -0.094; P < .001). Specificity was robust for both scores, but sensitivity was poorer for HFA-PEFF, with a false-negative rate of 55% for low-probability scores compared with 25% using the H2FPEF score. Use of the PCWP/CO slope to redefine HFpEF rather than exercise PCWP reclassified 20% (117 of 583) of patients, but patients reclassified from HFpEF to control by this metric had clinical, echocardiographic, and hemodynamic features typical of HFpEF, including elevated resting PCWP in 66% (46 of 70) of reclassified patients.In this case-control study, despite requiring fewer data, the H2FPEF score had superior diagnostic performance compared with the HFA-PEFF score and PCWP/CO slope in the evaluation of unexplained dyspnea and HFpEF in the outpatient setting.